Armstrong Advisory Group Portfolio holdings
Armstrong Advisory Group is a wealth management and financial planning firm for individuals and families, founded in 2004 as a collaboration of financial professionals. It is owned and run mainly by President Michael Armstrong, managing partners Brendan Hayes and Susan Powers, and chief investment officer Charles Zodda, who also co-hosts the daily Financial Exchange radio show on financial and business news. Education is central to its mission: it aims to help clients understand the complicated financial world. It is also related through common ownership to Armstrong Insurance Group, a life and health insurance agency.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$153M |
| 2 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$56.4M |
| 3 |
VanEck Gold Miners ETF
GDX
|
+$24.6M |
| 4 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$18.6M |
| 5 |
iShares MSCI Brazil ETF
EWZ
|
+$18.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard 0-3 Month Treasury Bill ETF
VBIL
|
+$72.6M |
| 2 |
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
|
+$71.7M |
| 3 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$55.6M |
| 4 |
Schwab 1000 Index ETF
SCHK
|
+$34.2M |
| 5 |
ROBO Global Robotics & Automation Index ETF
ROBO
|
+$17.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 88.7% |
| 2 | Technology | 4% |
| 3 | Industrials | 1.54% |
| 4 | Financials | 1.33% |
| 5 | Consumer Discretionary | 1.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1001
Ligand Pharmaceuticals
LGND
$6.18B
| $625 | ﹤0.01% |
+2
| New | +$591 |
2026 Q3
0 quarters
|
|
1002
Take-Two Interactive
TTWO
$42.7B
| $623 | ﹤0.01% |
3
-105
| -97% | -$24.3K |
2026 Q1
2 quarters
|
|
1003
Casey's General Stores
CASY
$26.3B
| $609 | ﹤0.01% |
+1
| New | +$771 |
2026 Q3
0 quarters
|
|
1004
Mueller Industries
MLI
$12B
| $607 | ﹤0.01% |
+10
| New | +$623 |
2026 Q3
0 quarters
|
|
1005
Gildan
GIL
$6.42B
| $597 | ﹤0.01% |
14
| – | – |
2025 Q4
3 quarters
|
|
1006
Guidewire Software
GWRE
$13.1B
| $571 | ﹤0.01% |
4
| – | – |
2025 Q4
3 quarters
|
|
1007
American Healthcare REIT
AHR
$13.4B
| $564 | ﹤0.01% |
11
| – | – |
2025 Q2
5 quarters
|
|
1008
Viatris
VTRS
$23.9B
| $560 | ﹤0.01% |
32
| – | – |
2022 Q4
15 quarters
|
|
1009
Curtiss-Wright
CW
$17.1B
| $544 | ﹤0.01% |
+1
| New | +$658 |
2026 Q3
0 quarters
|
|
1010
United Therapeutics
UTHR
$25.2B
| $542 | ﹤0.01% |
+1
| New | +$517 |
2026 Q3
0 quarters
|
|
1011
Williams Companies
WMB
$86.4B
| $476 | ﹤0.01% |
7
| – | – |
2025 Q2
5 quarters
|
|
1012
TripAdvisor
TRIP
$853M
| $461 | ﹤0.01% |
55
| – | – |
2023 Q1
14 quarters
|
|
1013
Ryanair
RYAAY
$29.9B
| $441 | ﹤0.01% |
8
| – | – |
2025 Q2
5 quarters
|
|
1014
JetBlue
JBLU
$1.42B
| $423 | ﹤0.01% |
100
| – | – |
2022 Q4
15 quarters
|
|
1015
Organon & Co
OGN
$3.65B
| $411 | ﹤0.01% |
30
| – | – |
2022 Q4
15 quarters
|
|
1016
Legence Corp
LGN
$2.69B
| $376 | ﹤0.01% |
+7
| New | +$434 |
2026 Q3
0 quarters
|
|
1017
DoorDash
DASH
$74.8B
| $368 | ﹤0.01% |
+2
| New | +$404 |
2026 Q3
0 quarters
|
|
1018
Royalty Pharma
RPRX
$30.9B
| $351 | ﹤0.01% |
+6
| New | +$354 |
2026 Q3
0 quarters
|
|
1019
Krystal Biotech
KRYS
$9.05B
| $333 | ﹤0.01% |
+1
| New | +$346 |
2026 Q3
0 quarters
|
|
1020
Twilio
TWLO
$32.7B
| $293 | ﹤0.01% |
+1
| New | +$228 |
2026 Q3
0 quarters
|
|
1021
BridgeBio Pharma
BBIO
$15.3B
| $198 | ﹤0.01% |
+3
| New | +$234 |
2026 Q3
0 quarters
|
|
1022
Angi Inc
ANGI
$265M
| $162 | ﹤0.01% |
28
| – | – |
2025 Q2
5 quarters
|
|
1023
OS Therapies Inc
OSTX
$34.9M
| $160 | ﹤0.01% |
100
| – | – |
2024 Q3
8 quarters
|
|
1024
Beam Global
BEEM
$16.2M
| $159 | ﹤0.01% |
140
| – | – |
2026 Q2
1 quarter
|
|
1025
Plug Power
PLUG
$1.55B
| $152 | ﹤0.01% |
78
-50
| -39% | -$109 |
2022 Q4
15 quarters
|
|
Similar funds
Armstrong Advisory Group's Q3 2026 Portfolio in Review
As of Q3 2026, Armstrong Advisory Group held 1,096 positions worth $1.66B, up 1.1% from $1.64B the previous quarter. Its ten largest holdings account for 66% of the portfolio.
Armstrong Advisory Group's Q3 2026 filing shows 110 new, 237 increased, 188 reduced and 55 closed positions. Its largest new stake was Vivmark Residential: 12,627 shares worth $767K. The largest sale was Vanguard 0-3 Month Treasury Bill ETF, an estimated $72.6M.
By sector, the portfolio is most concentrated in Miscellaneous at 89% of assets, down from 89% a quarter earlier, followed by Technology and Industrials.
- Armstrong Advisory Group's largest Q3 2026 buy was Vivmark Residential: 12,627 shares worth $767K.
- Armstrong Advisory Group added most to Vanguard Total Bond Market in Q3 2026, an estimated $153M increase.
- Armstrong Advisory Group's biggest Q3 2026 reduction was Vanguard 0-3 Month Treasury Bill ETF, cutting an estimated $72.6M.
- Armstrong Advisory Group fully exited AvalonBay Communities in Q3 2026, selling an estimated $845K.
- Armstrong Advisory Group's ten largest holdings make up 66% of its $1.66B portfolio in Q3 2026.
- Armstrong Advisory Group opened 110 new positions and closed 55 in Q3 2026.
- Armstrong Advisory Group's portfolio value rose 1.1% quarter-over-quarter to $1.66B.
Based on Armstrong Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.